Federico Lavorini is Professor of Respiratory Medicine at the Department of Clinical and Experimental Medicine, University of Florence Italy; he is also Head of the Respiratory and Critical Care Unit at the Careggi University Hospital, Florence, Italy. He qualified in Medicine at the University of Florence (1991), has the Specialist Certification in Respiratory Medicine (1996), and he also undertook a Ph.D. board certified in Applied Pathophysiology (2000). His research interests are control of breathing in health and disease, cough and inhalation devices for delivering aerosol medications. At the present, he is member of the Aerosol Drug Management Improvement Team (ADMIT), an european consortium of respiratory physician with special interests in aerosol medicine. He is also member of the Respiratory Effectiveness Group (REG), an investigator-led, social enterprise research initiatve. Federico Lavorini is Co-Chair of the European Respiratory Society /International Society of Aerosol in Medicine Taskforce on inhaled therapy and devices of the. He is also Chair of the Italian Respiratory Society (SIP) Taskforce on aerosol delivery systems. Federico Lavorini is Associate Editor and Review Editor of the Clinical Respiratory Journal, Respiratory Physiology and Pathophysiology, Frontiers in Physiology. He acts as Board member of the International Society for Aerosol in Medicine (ISAM), of the Journal of Aerosol Medicine and Pulmonary Drug Delivery, and of the BioMed Research International, Pulmonology.
